Back to results
US 11,077,072 B2Granted
Binge behavior regulators
AssigneeClearmind Medicine Inc.
InventorEzekiel Golan
Life of this patent
Estimating the term…
Abstract
Methods and compositions utilizing 2-aminoindan derivatives collectively represented by Formula I as described and defined in the specification for regulating binge behavior, particularly binge drinking, are disclosed.
Claims13
A method of regulating binge behavior, the method comprising administrating to a subject in need thereof a compound represented by Formula I:
- wherein:
- each of R1 and R2 is independently selected from the group consisting of H, (C1-C8)alkyl, (C2-C4)alkenyl, (C2-C8)alkynyl, (C3-C8)cycloalkyl, aryl, heteroaryl, heteroalicyclic, —O(C1-C6)alkyl, OH, —OS(═O)2CF3, —OS(═O)2—(C1-C6)alkyl, —S(═O)R5, —CO2R5, —CONR5R6, —COR5, —CF3, CN, —SR5, —SO2NR5R6, —SO2R5, —OCO—(C1-C6)alkyl, —NCO—(C1-C6)alkyl, —CH2O—(C1-C6)alkyl, —(C1-C6)alkyl-OH, and halogen, or, alternatively, R1 and R2 together with two or more of the phenyl carbon atoms form a X1—(CR5R6)m—X2— ring, wherein each of X1 and X2 is independently selected from O, NH or S and m is 1, 2, 3, or 4;
- each of R3 and R4 is independently selected from the group consisting of H, (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C3-C8) cycloalkyl, and —(CH2)p-thienyl, wherein p is 1, 2, 3, or 4, or alternatively, R3 and R4 are joined together to form a heterocylic ring (heteroalicyclic or heteroaryl) containing the nitrogen atom to which they are attached;
- and
- each of R5 and R6 is independently selected from the group consisting of H, (C1-C8)alkyl, (C2-C8)alkenyl, (C3-C8)cycloalkyl and aryl,
- thereby regulating the binge behavior,
- wherein at least one of R3 and R4 is H, and wherein the compound of Formula I is selected from:
- 5-methoxy-2-aminoindan;
- 5,6-dimethoxy-2-aminoindan;
- 5-methoxy-2-(N-propylamino)indan;
- 5,6-dimethoxy-2-(N-propylamino)indan;
- 5-(trifluoromethylsulfonyloxy)-2-(N-propylamino)indan;
- 5,6-(di-trifluoromethylsulfonyloxy)-2-(N-propylamino)Indan;
- and
- 5,6-dimethoxy-2(pyrrolidino)indan.
12 more elements
A pharmaceutical composition comprising 5-methoxy-2-aminoindan,
- the composition being formulated for oral administration, and being a liquid unit dosage form composition.
Dependencies are inferred from the claim text.